India’s Best ALK Inhibitor: Brigatinib Tablets

So, brigatinib is a drug that specifically targets the ALK inhibitor, used to treat a type of lung cancer known as ALK-positive metastatic non-small cell lung cancer, or NSCLC. It works by stopping a specific signal in the cancer cells called ALK, which in turn helps to slow down the growth of the cancer. There are three different strengths of the tablet: 30 mg, 90 mg, and 180 mg, and they all have that shiny coat on them.

So, you start with a 90 mg tablet every day for the first week, and then switch to a 180 mg tablet every day after that. Each bottle comes with 30 tablets. You got to start and keep an eye on this with a healthcare pro, because it can cause some serious stuff like liver problems, lung issues, and a longer heartbeat.